Oakland, New Jersey – October 12, 2010 – Topcon is presenting an array of new devices and software at the Annual Meeting of the American Academy of Ophthalmology (AAO) in Chicago (October 16‐19), the company announced today. Due to take place at …
Category: News
VEGF Blockers Seem Safe for Macular Degeneration (CME/CE)
(MedPage Today) — Using vascular endothelial growth factor (VEGF) blockers to treat neovascular age-related macular degeneration does not appear to increase the risk of serious cardiovascular events, a retrospective study showed.
IRIDEX Announces Commercial Availability Of New Adjustable & Intuitive EndoProbe® Device For Eye Surgery
IRIDEX Corporation today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company’s laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser Probes speed up treatm…
IRIDEX Announces Commercial Availability Of New Adjustable & Intuitive EndoProbe® Device For Eye Surgery
IRIDEX Corporation today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company’s laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser Probes speed up treatm…
Going to AAO 2010? View Our Exclusive Exhibit Hall Preview
Featured Article
Anti-VEGF Therapy Produces Significant Reduction In Anatomical Measures Of CNV
Treatment of neovascular age-related macular degeneration with anti-VEGF therapy leads to rapid reduction of lesion size that is evident on optical coherence tomography.
Alcon Introduces New Systane(R) BALANCE Lubricant Eye Drops For Dry Eye Patients With Meibomian Gland Dysfunction
Alcon, Inc. (NYSE: ACL), the world’s leader in eye care, announced the launch of Systane(R) BALANCE Lubricant Eye Drops, the newest lubricant eye drop in the Systane(R) family of products. Patients with Meibomian Gland Dysfunction (MGD) are unable to a…
Going to AAO 2010? View Our Exclusive Exhibit Hall Preview
Featured Article
Alcon Introduces New Systane(R) BALANCE Lubricant Eye Drops For Dry Eye Patients With Meibomian Gland Dysfunction
Alcon, Inc. (NYSE: ACL), the world’s leader in eye care, announced the launch of Systane(R) BALANCE Lubricant Eye Drops, the newest lubricant eye drop in the Systane(R) family of products. Patients with Meibomian Gland Dysfunction (MGD) are unable to a…
Anti-VEGF Therapy Produces Significant Reduction In Anatomical Measures Of CNV
Treatment of neovascular age-related macular degeneration with anti-VEGF therapy leads to rapid reduction of lesion size that is evident on optical coherence tomography.
Gambian Study Shows High Trichiasis Recurrence Rate At 4 Years Postop
Trichiasis recurrence rates in The Gambia were high up to 4 years after initial treatment, a study found.
Glaucoma Imaging Measurements Influenced By Cataracts
The presence of cataracts affected the image quality taken by glaucoma imaging devices, and phacoemulsification improved measurements in all cases after cataract removal, a study found.
Glaucoma Imaging Measurements Influenced By Cataracts
The presence of cataracts affected the image quality taken by glaucoma imaging devices, and phacoemulsification improved measurements in all cases after cataract removal, a study found.
Glaucoma Imaging Measurements Influenced By Cataracts
The presence of cataracts affected the image quality taken by glaucoma imaging devices, and phacoemulsification improved measurements in all cases after cataract removal, a study found.
Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion
New Cochrane review issued on 6th October 2010.
Glaucoma – Suspected acute angle closure glaucoma – emergency management in primary care
This scenario covers the emergency management in primary care of suspected acute glaucoma when immediate admission is not practical.
Glaucoma – Diagnosis of glaucoma and ocular hypertension
This scenario covers when to suspect acute or chronic glaucoma, and how to identify people at high risk of glaucoma who should be advised to have their eyes tested.
Glaucoma – Chronic open angle glaucoma -confirmed or suspected- or ocular hypertension
This scenario describes the primary healthcare professional’s role in the shared care management of chronic open angle glaucoma (confirmed or suspected) or ocular hypertension.
Glaucoma and ocular hypertension
This CKS topic is based on the guideline Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension developed by the National institute for Health and Clinical Excellence (NICE) and takes account of guidelines developed b…
From eye to brain: Researchers map functional connections between retinal neurons at single-cell resolution
By comparing a clearly defined visual input with the electrical output of the retina, researchers were able to trace for the first time the neuronal circuitry that connects individual photoreceptors with retinal ganglion cells, the neurons that carry v…